ArticleMedicina (Kaunas, Lithuania)2023

Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.

Radha Gopalaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.